Registry of Chronic Subdural Hematoma
Erasmus Medical Center
1,500 participants
Oct 1, 2021
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to better understand how chronic subdural hematoma (CSDH) progresses and how patients are treated and cared for. The study focuses on three main questions: 1. What are the characteristics of patients with CSDH when they are diagnosed? 2. What treatments do patients with CSDH receive? 3. What are the outcomes for patients with CSDH, including their functional ability, cognitive health, and neurological status? Participants will receive their usual standard treatment. As part of the study, they will complete a brief telephone interview three months after their treatment.
Eligibility
Inclusion Criteria2
- Patients diagnosed with CSDH
- years or older
Exclusion Criteria1
- Patients who do not consent to participate in the registry
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06759428